Learning Objectives

By the end of this chapter, learners will be able to:
1. Define nephritic syndrome and distinguish it from nephrotic syndrome
2. Understand the pathophysiology of acute glomerular inflammation
3. Identify the clinical manifestations and laboratory findings
4. Recognize the major causes of nephritic syndrome
5. Describe the diagnostic approach and differential diagnosis
6. Outline treatment strategies for acute glomerulonephritis
7. Understand complications and prognosis
8. Recognize when urgent intervention is required

Introduction and Definition

Nephritic syndrome represents an acute inflammatory condition of the glomeruli characterized by the sudden onset of hematuria, proteinuria (typically <3.5 g/day), hypertension, edema, and often oliguria with acute kidney injury. Unlike nephrotic syndrome, which primarily involves increased glomerular permeability to proteins, nephritic syndrome results from acute inflammatory damage to the glomerular capillaries, leading to disruption of the glomerular basement membrane and allowing red blood cells to pass into the urine.

The syndrome typically presents as an acute illness with rapid onset over days to weeks, contrasting with the more insidious presentation often seen in nephrotic syndrome. The inflammatory nature of the condition means that patients may also experience systemic symptoms such as malaise, fever, and arthralgia, depending on the underlying cause.

Nephritic syndrome can occur at any age but shows distinct patterns of causation across different age groups. In children, post-infectious glomerulonephritis is the most common cause, while in adults, a broader range of conditions including systemic diseases, vasculitis, and rapidly progressive glomerulonephritis must be considered.

The prognosis of nephritic syndrome varies significantly depending on the underlying cause, with some conditions resolving completely while others may progress rapidly to end-stage renal disease if not promptly recognized and treated. Early recognition and appropriate management are crucial for optimal outcomes.

Pathophysiology

The pathophysiology of nephritic syndrome centers on acute inflammatory injury to the glomerular capillaries, resulting in disruption of the glomerular filtration barrier and activation of inflammatory cascades. This inflammatory process can be triggered by various mechanisms including immune complex deposition, anti-glomerular basement membrane antibodies, antineutrophil cytoplasmic antibodies (ANCA), or direct infectious agents.

Immune complex-mediated injury is the most common mechanism, occurring when circulating immune complexes deposit in the glomerular capillaries or when in-situ immune complex formation occurs within the glomerulus. These immune complexes activate complement, leading to recruitment of inflammatory cells including neutrophils, monocytes, and T lymphocytes. The inflammatory response results in endothelial cell swelling, mesangial cell proliferation, and disruption of the glomerular basement membrane.

The complement system plays a central role in the inflammatory process, with activation leading to the formation of membrane attack complexes that directly damage glomerular cells. Complement activation also generates chemotactic factors that recruit inflammatory cells and promote further tissue damage. The degree of complement activation often correlates with the severity of the glomerular injury.

Anti-GBM antibodies cause a different pattern of injury by directly binding to the α3 chain of type IV collagen in the glomerular and alveolar basement membranes. This binding triggers complement activation and inflammatory cell recruitment, leading to rapidly progressive glomerulonephritis and often pulmonary hemorrhage (Goodpasture’s syndrome).

ANCA-associated vasculitis affects small vessels including glomerular capillaries through mechanisms involving neutrophil activation and degranulation. ANCA antibodies bind to neutrophil granule proteins (proteinase 3 or myeloperoxidase) that have translocated to the cell surface, leading to neutrophil activation, degranulation, and endothelial damage.

The inflammatory injury results in several characteristic pathophysiological changes. Disruption of the glomerular basement membrane allows red blood cells to pass into the urine, causing hematuria. The inflammatory process also increases glomerular permeability to proteins, though typically to a lesser degree than seen in nephrotic syndrome.

Acute reduction in glomerular filtration rate occurs due to several mechanisms including decreased glomerular surface area from inflammatory cell infiltration, reduced glomerular perfusion from vasoconstriction and microthrombi, and tubular obstruction from red blood cell casts and debris. This reduction in GFR leads to retention of sodium, water, and nitrogenous wastes.

Hypertension in nephritic syndrome results primarily from volume expansion due to sodium and water retention. The acute nature of the volume expansion often leads to more severe hypertension than seen in chronic kidney disease, and may be associated with complications such as hypertensive encephalopathy or pulmonary edema.

Clinical Manifestations

The clinical presentation of nephritic syndrome is typically acute and dramatic, with patients often presenting within days to weeks of symptom onset. The constellation of findings reflects the underlying inflammatory process and its effects on glomerular function and systemic hemodynamics.

Hematuria is the hallmark of nephritic syndrome and may be either gross (visible) or microscopic. Gross hematuria often appears as “tea-colored,” “cola-colored,” or “smoky” urine, reflecting the presence of red blood cells that have been altered during passage through the nephron. The hematuria is typically persistent and may be associated with red blood cell casts, which are pathognomonic of glomerular bleeding.

Proteinuria is present but typically less severe than in nephrotic syndrome, usually ranging from 1-3 grams per day. The proteinuria reflects increased glomerular permeability due to inflammatory damage but is generally not sufficient to cause significant hypoalbuminemia or the full nephrotic syndrome.

Edema in nephritic syndrome typically has a different pattern than in nephrotic syndrome. It often begins in the face, particularly around the eyes (periorbital edema), and may be more prominent in the morning. The edema is usually less severe than in nephrotic syndrome but can progress to involve the extremities and, in severe cases, cause pulmonary edema.

Hypertension is common and may be severe, reflecting the acute volume expansion. Blood pressure elevation can occur rapidly and may be associated with symptoms such as headache, visual disturbances, or altered mental status. In severe cases, hypertensive emergency with encephalopathy, seizures, or heart failure may occur.

Oliguria (decreased urine output) is frequently present and reflects the acute reduction in glomerular filtration rate. Patients may notice a significant decrease in urine volume, and in severe cases, anuria may occur. The oliguria contributes to fluid retention and the development of edema and hypertension.

Systemic symptoms are common and may include malaise, fatigue, nausea, and vomiting. Fever may be present, particularly in post-infectious glomerulonephritis or when associated with systemic diseases. Arthralgia and myalgia may occur, especially in cases associated with systemic lupus erythematosus or other autoimmune conditions.

Respiratory symptoms may develop due to pulmonary edema from volume overload or, in cases of anti-GBM disease, due to pulmonary hemorrhage. Patients may experience dyspnea, cough, or hemoptysis, and chest imaging may show pulmonary infiltrates or edema.

The acute nature of nephritic syndrome often leads patients to seek medical attention promptly, in contrast to nephrotic syndrome which may have a more insidious onset. The combination of visible hematuria, edema, and hypertension in an acutely ill patient should immediately raise suspicion for nephritic syndrome.

Etiology and Classification

Nephritic syndrome can be caused by a variety of conditions that result in acute glomerular inflammation. These can be broadly classified into primary glomerular diseases and secondary conditions affecting the glomeruli.

Post-infectious glomerulonephritis is the most common cause of nephritic syndrome in children and remains an important cause in adults, particularly in developing countries. The classic form follows group A beta-hemolytic streptococcal infection of the throat or skin by 1-3 weeks. The latent period reflects the time required for immune complex formation and deposition. Other infectious agents that can cause post-infectious glomerulonephritis include staphylococci, pneumococci, viral infections (hepatitis B and C, Epstein-Barr virus), and parasitic infections (malaria, schistosomiasis).

IgA nephropathy (Berger’s disease) is the most common primary glomerulonephritis worldwide and can present with nephritic syndrome, particularly during episodes of gross hematuria that often coincide with upper respiratory infections. The condition is characterized by IgA deposition in the glomerular mesangium and can have a variable course from benign recurrent hematuria to progressive chronic kidney disease.

Rapidly progressive glomerulonephritis (RPGN) represents a medical emergency characterized by rapid loss of renal function over days to weeks, often accompanied by nephritic syndrome. RPGN can be classified into three types based on immunofluorescence findings: Type I (anti-GBM disease), Type II (immune complex-mediated), and Type III (pauci-immune, usually ANCA-associated).

Anti-GBM disease (Goodpasture’s syndrome) is a rare but serious cause of nephritic syndrome that can rapidly progress to end-stage renal disease. It is characterized by antibodies directed against the α3 chain of type IV collagen in the glomerular and alveolar basement membranes. Patients may present with both glomerulonephritis and pulmonary hemorrhage.

ANCA-associated vasculitis includes granulomatosis with polyangiitis (formerly Wegener’s granulomatosis), microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome). These conditions can present with nephritic syndrome and often involve multiple organ systems.

Systemic lupus erythematosus can cause various forms of lupus nephritis, with Class III (focal proliferative) and Class IV (diffuse proliferative) lupus nephritis typically presenting with nephritic syndrome. These forms are associated with significant morbidity and require aggressive immunosuppressive therapy.

Membranoproliferative glomerulonephritis (MPGN) can present with nephritic syndrome, nephrotic syndrome, or a mixed picture. It is characterized by mesangial proliferation and capillary wall changes and can be primary or secondary to various systemic conditions including infections, autoimmune diseases, or complement abnormalities.

Hereditary nephritis (Alport syndrome) is a genetic condition affecting type IV collagen that can present with nephritic syndrome, particularly during episodes of gross hematuria. It is associated with sensorineural hearing loss and ocular abnormalities.

Acute interstitial nephritis, while primarily affecting the tubulointerstitium, can occasionally present with features of nephritic syndrome, particularly when associated with drug reactions or infections.

Diagnostic Approach

The diagnostic evaluation of nephritic syndrome requires urgent and systematic assessment to identify the underlying cause and assess the severity of renal involvement. The acute nature of the condition and potential for rapid progression make prompt evaluation essential.

The history should focus on recent infections, particularly streptococcal throat or skin infections in the preceding 1-3 weeks. A detailed medication history is important to identify potential drug-induced causes. Family history of kidney disease or hearing loss may suggest hereditary nephritis. Systemic symptoms such as joint pain, rash, or respiratory symptoms may indicate systemic diseases.

Physical examination should assess for signs of volume overload including edema, elevated blood pressure, and pulmonary congestion. Skin examination may reveal rashes suggestive of systemic lupus erythematosus or vasculitis. Fundoscopic examination may show hypertensive retinopathy or other abnormalities.

Laboratory evaluation should begin with urinalysis, which typically shows hematuria (often with red blood cell casts), proteinuria, and may show white blood cells and granular casts. The presence of red blood cell casts is particularly important as it confirms glomerular origin of the hematuria.

Quantification of proteinuria through 24-hour urine collection or spot protein-to-creatinine ratio helps distinguish nephritic from nephrotic syndrome. Serum creatinine and blood urea nitrogen assess renal function and help determine the severity of acute kidney injury.

Complete blood count may show anemia, which can develop rapidly in severe cases due to hemolysis, bleeding, or decreased erythropoietin production. Thrombocytopenia may be present in certain conditions such as thrombotic thrombocytopenic purpura or systemic lupus erythematosus.

Complement levels (C3, C4, CH50) are crucial in the evaluation of nephritic syndrome. Low C3 levels are characteristic of post-infectious glomerulonephritis, MPGN, and lupus nephritis. Normal complement levels are typical of IgA nephropathy and ANCA-associated vasculitis.

Serological studies should include antistreptolysin O (ASO) and anti-DNase B titers to assess for recent streptococcal infection. Anti-nuclear antibodies (ANA) and anti-double-stranded DNA antibodies help evaluate for systemic lupus erythematosus. ANCA testing (c-ANCA/PR3 and p-ANCA/MPO) is important for diagnosing ANCA-associated vasculitis.

Anti-GBM antibodies should be measured in patients with rapidly progressive glomerulonephritis, particularly if there are pulmonary symptoms. Hepatitis B and C serologies are important as these infections can cause glomerulonephritis.

Imaging studies should include chest X-ray to assess for pulmonary edema or infiltrates. Renal ultrasound can assess kidney size and structure and rule out obstruction. Echocardiography may be indicated if there are signs of volume overload or heart failure.

Renal biopsy is often necessary for definitive diagnosis, particularly in adults or when the clinical presentation is atypical. The timing of biopsy depends on the clinical scenario, but in rapidly progressive cases, biopsy should be performed urgently to guide therapy.

Treatment Strategies

The treatment of nephritic syndrome involves both specific therapy directed at the underlying cause and supportive care to manage complications and preserve renal function. The approach must be individualized based on the specific diagnosis, severity of presentation, and patient factors.

Supportive care is essential for all patients with nephritic syndrome and focuses on managing volume overload, hypertension, and preserving renal function. Sodium restriction (2-3 grams per day) and fluid restriction may be necessary to control edema and hypertension. Loop diuretics such as furosemide are often required for volume management, though care must be taken to avoid volume depletion that could worsen renal function.

Antihypertensive therapy is crucial and should target blood pressure control while preserving renal perfusion. ACE inhibitors or angiotensin receptor blockers are preferred agents as they provide both blood pressure control and potential renoprotection. In severe hypertension, additional agents such as calcium channel blockers or beta-blockers may be necessary.

Specific therapy depends on the underlying cause and may include immunosuppressive medications, plasmapheresis, or antimicrobial therapy. The urgency of treatment varies significantly based on the diagnosis, with some conditions requiring immediate intervention while others may be managed conservatively.

Post-infectious glomerulonephritis typically requires only supportive care, as the condition is usually self-limited. Antibiotic therapy should be given if there is evidence of ongoing infection, but antibiotics do not alter the course of the glomerulonephritis itself. Most patients recover completely, though a small percentage may develop chronic kidney disease.

Rapidly progressive glomerulonephritis requires urgent immunosuppressive therapy to prevent irreversible renal damage. The standard regimen typically includes high-dose corticosteroids (methylprednisolone 500-1000 mg IV daily for 3 days followed by oral prednisone) combined with cyclophosphamide. Plasmapheresis may be added in severe cases, particularly in anti-GBM disease or severe ANCA-associated vasculitis.

Anti-GBM disease requires aggressive treatment with the combination of corticosteroids, cyclophosphamide, and plasmapheresis. Treatment should be initiated as soon as possible, as delays in therapy are associated with poor renal outcomes. Plasmapheresis is typically performed daily for 2 weeks or until anti-GBM antibodies become undetectable.

ANCA-associated vasculitis treatment is divided into induction and maintenance phases. Induction therapy typically includes corticosteroids and cyclophosphamide, with rituximab being an alternative to cyclophosphamide in certain cases. Plasmapheresis may be added for severe cases with pulmonary hemorrhage or severe renal involvement.

Lupus nephritis treatment depends on the histological class but typically involves high-dose corticosteroids combined with other immunosuppressive agents such as mycophenolate mofetil, cyclophosphamide, or calcineurin inhibitors. The choice of agent depends on various factors including severity, patient age, and comorbidities.

IgA nephropathy treatment is controversial, with supportive care being the mainstay for most patients. ACE inhibitors or ARBs are recommended for blood pressure control and proteinuria reduction. Corticosteroids may be considered in patients with persistent proteinuria and preserved renal function, though the evidence is mixed.

Monitoring during treatment is essential and should include regular assessment of renal function, urinalysis, blood pressure, and drug toxicity. Response to therapy is typically assessed by improvement in renal function, reduction in proteinuria and hematuria, and resolution of systemic symptoms.

Complications and Management

Nephritic syndrome can be associated with several serious complications that require prompt recognition and management. The acute nature of the condition and potential for rapid progression make vigilant monitoring essential.

Acute kidney injury is a common and potentially serious complication that can range from mild elevation in creatinine to complete anuria requiring dialysis. The degree of renal impairment often correlates with the severity of the underlying glomerular inflammation and the promptness of treatment. In severe cases, acute kidney injury may progress to chronic kidney disease or end-stage renal disease.

Hypertensive emergency can occur due to the rapid volume expansion and may present with symptoms such as severe headache, visual disturbances, altered mental status, or seizures. Management requires careful blood pressure reduction to avoid precipitating cerebral, cardiac, or renal ischemia. The goal is typically to reduce blood pressure by 10-20% in the first hour and then gradually over 24 hours.

Pulmonary edema can develop rapidly due to volume overload and may be life-threatening. Patients may present with dyspnea, orthopnea, and bilateral pulmonary infiltrates on chest imaging. Treatment includes aggressive diuresis, blood pressure control, and in severe cases, mechanical ventilation and dialysis.

Cerebral complications can include hypertensive encephalopathy, seizures, and stroke. These complications are more common in children and may be the presenting feature of nephritic syndrome. Management includes blood pressure control, anticonvulsants if seizures occur, and supportive care.

Cardiovascular complications may include heart failure due to volume overload and hypertension, arrhythmias due to electrolyte abnormalities, and in severe cases, myocardial infarction. Careful fluid and electrolyte management is essential, along with appropriate cardiac monitoring.

Electrolyte abnormalities are common and may include hyperkalemia due to reduced renal function, hyponatremia due to water retention, and hyperphosphatemia with hypocalcemia in severe cases. These abnormalities require careful monitoring and correction as appropriate.

Infection risk may be increased, particularly in patients receiving immunosuppressive therapy. Patients should be monitored for signs of infection and receive appropriate prophylaxis when indicated. Live vaccines should be avoided in immunosuppressed patients.

Thrombotic complications, while less common than in nephrotic syndrome, can occur particularly in patients with severe disease or those receiving high-dose corticosteroids. Prophylactic anticoagulation may be considered in high-risk patients.

Chronic complications may develop in patients who do not achieve complete recovery. These can include chronic kidney disease with progressive loss of renal function, persistent hypertension requiring ongoing antihypertensive therapy, and in some cases, progression to end-stage renal disease requiring dialysis or transplantation.

Prognosis and Long-term Management

The prognosis of nephritic syndrome varies significantly depending on the underlying cause, severity of presentation, and response to treatment. Understanding these prognostic factors is essential for patient counseling and treatment planning.

Post-infectious glomerulonephritis generally has an excellent prognosis, particularly in children. Complete recovery occurs in over 95% of children, with resolution of hematuria, proteinuria, and renal function abnormalities typically within 6-12 months. Adults may have a slightly less favorable prognosis, with a small percentage developing chronic kidney disease.

IgA nephropathy has a variable prognosis, with many patients having a benign course characterized by recurrent episodes of hematuria without significant loss of renal function. However, approximately 20-30% of patients may progress to chronic kidney disease over 10-20 years. Factors associated with poor prognosis include persistent proteinuria, hypertension, reduced renal function at presentation, and certain histological features.

Rapidly progressive glomerulonephritis has a poor prognosis without treatment, with most patients progressing to end-stage renal disease within weeks to months. However, with prompt and aggressive treatment, significant recovery of renal function is possible, particularly if treatment is initiated before extensive irreversible damage has occurred.

Anti-GBM disease has a generally poor renal prognosis, with most patients requiring dialysis despite treatment. However, early aggressive treatment can preserve some renal function in a subset of patients. The pulmonary component typically responds well to treatment, and anti-GBM antibodies usually become undetectable with therapy.

ANCA-associated vasculitis has improved significantly in prognosis with modern immunosuppressive regimens. Remission can be achieved in 70-90% of patients, though relapses are common and require ongoing monitoring. Long-term prognosis depends on the extent of initial organ damage and response to therapy.

Lupus nephritis prognosis has improved with better understanding of the disease and improved treatment regimens. Complete or partial remission can be achieved in 60-80% of patients with proliferative lupus nephritis, though long-term outcomes remain variable and depend on multiple factors including ethnicity, socioeconomic status, and adherence to therapy.

Long-term management focuses on monitoring for disease recurrence, managing chronic complications, and preserving remaining renal function. Regular follow-up should include assessment of renal function, urinalysis, blood pressure monitoring, and screening for complications of chronic kidney disease if present.

Patients who achieve remission should continue to be monitored for relapse, which may occur months to years after initial treatment. The frequency of monitoring depends on the underlying diagnosis and risk factors for relapse.

Lifestyle modifications are important for long-term management and include maintaining a healthy diet with appropriate protein and sodium intake, regular exercise as tolerated, smoking cessation, and weight management. Patients should be educated about signs and symptoms of relapse that require immediate medical attention.

Transition of care from acute management to long-term follow-up requires coordination between nephrologists, primary care physicians, and other specialists as appropriate. This is particularly important for patients with systemic diseases that require ongoing management of multiple organ systems.

Summary

Nephritic syndrome is an acute inflammatory condition of the glomeruli characterized by hematuria, proteinuria, hypertension, edema, and often acute kidney injury. The syndrome results from acute inflammatory damage to the glomerular capillaries, leading to disruption of the glomerular basement membrane and allowing red blood cells to pass into the urine.

The pathophysiology involves various mechanisms of glomerular injury including immune complex deposition, anti-GBM antibodies, and ANCA-associated inflammation. These processes lead to complement activation, inflammatory cell recruitment, and direct tissue damage, resulting in the characteristic clinical manifestations.

Clinical presentation is typically acute with rapid onset of symptoms over days to weeks. The combination of gross hematuria, edema, and hypertension in an acutely ill patient should raise immediate suspicion for nephritic syndrome. Red blood cell casts in the urine are pathognomonic of glomerular bleeding.

The differential diagnosis includes post-infectious glomerulonephritis, IgA nephropathy, rapidly progressive glomerulonephritis, anti-GBM disease, ANCA-associated vasculitis, and lupus nephritis. Diagnostic evaluation requires urgent assessment including urinalysis, renal function tests, complement levels, and specific serological studies.

Treatment involves both supportive care to manage complications and specific therapy directed at the underlying cause. Supportive care includes volume management, blood pressure control, and preservation of renal function. Specific therapy may include immunosuppressive medications, plasmapheresis, or antimicrobial therapy depending on the diagnosis.

Complications can be serious and include acute kidney injury, hypertensive emergency, pulmonary edema, and cerebral complications. Prompt recognition and management of these complications are essential for optimal outcomes.

Prognosis varies significantly based on the underlying cause, with post-infectious glomerulonephritis having an excellent prognosis while rapidly progressive forms may lead to end-stage renal disease without prompt treatment. Long-term management focuses on monitoring for recurrence and managing chronic complications.

Clinical Pearls

1. Red Blood Cell Casts: The presence of red blood cell casts in urine is pathognomonic of glomerular bleeding and distinguishes nephritic syndrome from other causes of hematuria.

2. Complement Pattern Recognition: Low C3 with normal C4 suggests post-infectious GN or MPGN; low C3 and C4 suggests lupus nephritis; normal complements suggest IgA nephropathy or ANCA vasculitis.

3. Latent Period Importance: Post-streptococcal GN typically occurs 1-3 weeks after throat infection or 3-6 weeks after skin infection – this timing is crucial for diagnosis.

4. Hypertensive Emergency Risk: Acute volume expansion in nephritic syndrome can cause severe hypertension requiring careful blood pressure reduction (10-20% in first hour).

5. RPGN Urgency: Any patient with nephritic syndrome and rapidly rising creatinine needs immediate evaluation and likely urgent renal biopsy – time is kidney function.

6. Anti-GBM Window: Anti-GBM disease has a narrow therapeutic window; treatment must begin within days to preserve renal function.

7. Oliguria Significance: Oliguria in nephritic syndrome often indicates severe glomerular damage and higher risk of progression to chronic kidney disease.

8. Pulmonary-Renal Syndrome: Combination of glomerulonephritis and pulmonary hemorrhage suggests anti-GBM disease, ANCA vasculitis, or lupus – requires immediate aggressive treatment.

9. Age-Related Causes: Children: post-infectious GN most common; Adults: broader differential including RPGN, vasculitis, and lupus nephritis.

10. Diuretic Caution: While diuretics are needed for volume control, avoid over-diuresis which can worsen acute kidney injury.

11. Steroid Timing: In RPGN, corticosteroids should be started immediately while awaiting biopsy results – don’t delay treatment for tissue diagnosis.

12. Recovery Monitoring: Complete recovery in post-infectious GN may take 6-12 months; persistent abnormalities beyond this timeframe suggest alternative diagnosis.

Recommended Diagrams and Images:

1. Glomerular Inflammation Pathophysiology: Flowchart showing immune complex deposition leading to complement activation and inflammatory cell recruitment
2. Nephritic vs. Nephrotic Comparison Table: Side-by-side comparison of clinical features, laboratory findings, and causes
3. Urine Microscopy Findings: Images showing red blood cell casts, dysmorphic RBCs, and other urinary sediment findings
4. Complement Cascade Activation: Diagram showing classical and alternative pathway activation in glomerulonephritis
5. RPGN Classification: Visual classification of Type I (anti-GBM), Type II (immune complex), and Type III (pauci-immune) RPGN
6. Post-infectious GN Timeline: Timeline showing relationship between infection and onset of glomerulonephritis
7. Renal Biopsy Findings: Light microscopy images showing endocapillary proliferation, crescents, and immune deposits
8. Clinical Presentation Algorithm: Decision tree for evaluating acute glomerulonephritis
9. Treatment Response Monitoring: Graphs showing typical recovery patterns for different causes
10. Complications Management: Flowchart for managing hypertensive emergency and pulmonary edema

Laboratory Images:

• Urinalysis showing red blood cell casts and proteinuria
• Immunofluorescence patterns in different types of glomerulonephritis
• Electron microscopy showing subepithelial, subendothelial, and mesangial deposits

Clinical Photography:

• Periorbital edema in acute glomerulonephritis
• “Tea-colored” or “cola-colored” urine
• Hypertensive retinopathy findings

Slide 1: Title Slide

• Title: Nephritic Syndrome: Acute Glomerular Inflammation
• Subtitle: Recognition, Diagnosis, and Emergency Management
• NephroHub Watermark

Slide 2: Learning Objectives

• Define nephritic syndrome and distinguish from nephrotic syndrome
• Understand pathophysiology of acute glomerular inflammation
• Recognize clinical manifestations and laboratory findings
• Identify major causes and diagnostic approach
• Outline treatment strategies and complication management

Slide 3: Definition and Key Features

• Acute onset hematuria with RBC casts
• Proteinuria (<3.5 g/day typically)
• Hypertension and edema
• Often oliguria and acute kidney injury
• Inflammatory vs. non-inflammatory glomerular disease

Slide 4: Nephritic vs. Nephrotic Syndrome

• Comparison table of clinical features
• Laboratory findings differences
• Pathophysiology distinctions
• Overlapping presentations

Slide 5: Pathophysiology Overview

• Immune complex deposition mechanisms
• Complement activation cascade
• Inflammatory cell recruitment
• Glomerular basement membrane disruption

Slide 6: Clinical Presentation

• Acute onset over days to weeks
• Gross hematuria (“tea-colored” urine)
• Periorbital and dependent edema
• Hypertension (often severe)
• Oliguria and systemic symptoms

Slide 7: Urinalysis Findings

• Red blood cell casts (pathognomonic)
• Dysmorphic red blood cells
• Proteinuria (usually <3.5 g/day)
• White blood cells and granular casts

Slide 8: Post-infectious Glomerulonephritis

• Most common cause in children
• Latent period after streptococcal infection
• Clinical features and laboratory findings
• Excellent prognosis with supportive care

Slide 9: Rapidly Progressive GN (RPGN)

• Medical emergency requiring urgent intervention
• Three types: anti-GBM, immune complex, pauci-immune
• Crescentic glomerulonephritis on biopsy
• Aggressive immunosuppressive treatment

Slide 10: IgA Nephropathy

• Most common primary glomerulonephritis worldwide
• Episodic gross hematuria with URI
• Variable prognosis
• Supportive care with ACE inhibitors/ARBs

Slide 11: ANCA-Associated Vasculitis

• Small vessel vasculitis affecting glomeruli
• c-ANCA (PR3) and p-ANCA (MPO) patterns
• Multi-system involvement
• Induction and maintenance therapy phases

Slide 12: Anti-GBM Disease

• Goodpasture’s syndrome
• Pulmonary-renal syndrome
• Anti-GBM antibodies
• Triple therapy: steroids, cyclophosphamide, plasmapheresis

Slide 13: Lupus Nephritis

• Class III and IV present with nephritic features
• ANA, anti-dsDNA, low complements
• Aggressive immunosuppressive therapy
• Long-term monitoring for flares

Slide 14: Diagnostic Approach

• Urgent evaluation required
• Urinalysis with microscopy
• Complement levels (C3, C4)
• Serological studies
• Renal biopsy indications

Slide 15: Laboratory Evaluation

• Complete blood count and chemistry
• Complement levels interpretation
• Serological markers (ASO, ANA, ANCA, anti-GBM)
• Urinalysis and proteinuria quantification

Slide 16: Supportive Care

• Volume and blood pressure management
• Sodium and fluid restriction
• Loop diuretics for edema
• ACE inhibitors/ARBs for hypertension

Slide 17: Specific Therapies

• Immunosuppressive protocols
• Corticosteroids and cyclophosphamide
• Plasmapheresis indications
• Rituximab and newer agents

Slide 18: Complications Management

• Hypertensive emergency
• Pulmonary edema
• Acute kidney injury
• Cerebral complications

Slide 19: Emergency Situations

• RPGN recognition and management
• Pulmonary-renal syndrome
• Hypertensive encephalopathy
• When to start treatment before biopsy

Slide 20: Prognosis by Cause

• Post-infectious GN: excellent
• IgA nephropathy: variable
• RPGN: poor without treatment
• Anti-GBM: generally poor renal prognosis

Slide 21: Long-term Management

• Monitoring for recurrence
• Chronic kidney disease management
• Immunosuppression tapering
• Lifestyle modifications

Slide 22: Key Clinical Pearls

• RBC casts = glomerular bleeding
• Complement patterns aid diagnosis
• Time is critical in RPGN
• Don’t delay treatment for biopsy in emergencies

Slide 23: Case Study

• Acute presentation
• Diagnostic workup
• Treatment decisions
• Outcome and follow-up

Slide 24: Summary and Conclusions

• Recognition of acute glomerulonephritis
• Urgent evaluation and treatment
• Cause-specific management
• Importance of early intervention

Question 1

A 12-year-old boy presents with tea-colored urine, periorbital edema, and hypertension 2 weeks after a sore throat. Urinalysis shows 3+ blood, 2+ protein, and red blood cell casts. What is the most likely diagnosis?

A) IgA nephropathy
B) Post-infectious glomerulonephritis
C) Rapidly progressive glomerulonephritis
D) Minimal change disease
E) Acute tubular necrosis

Correct Answer: B) Post-infectious glomerulonephritis

Explanation: The classic presentation of nephritic syndrome 1-3 weeks after streptococcal throat infection in a child is characteristic of post-infectious glomerulonephritis. The presence of RBC casts confirms glomerular origin.

Question 2

Which urinalysis finding is pathognomonic of glomerular bleeding?

A) Gross hematuria
B) Proteinuria >3.5 g/day
C) Red blood cell casts
D) White blood cell casts
E) Granular casts

Correct Answer: C) Red blood cell casts

Explanation: Red blood cell casts are formed when RBCs pass through the glomerulus and become trapped in tubular protein matrix, making them pathognomonic of glomerular bleeding.

Question 3

A 45-year-old man presents with rapidly progressive kidney failure over 2 weeks, gross hematuria, and hemoptysis. Anti-GBM antibodies are positive. What is the most appropriate initial treatment?

A) Corticosteroids alone
B) ACE inhibitors and supportive care
C) Corticosteroids, cyclophosphamide, and plasmapheresis
D) Rituximab
E) Dialysis only

Correct Answer: C) Corticosteroids, cyclophosphamide, and plasmapheresis

Explanation: Anti-GBM disease (Goodpasture’s syndrome) requires aggressive triple therapy with corticosteroids, cyclophosphamide, and plasmapheresis to remove circulating antibodies.

Question 4

Which complement pattern is most characteristic of post-infectious glomerulonephritis?

A) Low C3, low C4
B) Low C3, normal C4
C) Normal C3, low C4
D) Normal C3, normal C4
E) High C3, high C4

Correct Answer: B) Low C3, normal C4

Explanation: Post-infectious glomerulonephritis typically shows low C3 with normal C4 due to alternative complement pathway activation. Low C3 and C4 would suggest lupus nephritis.

Question 5

A patient with nephritic syndrome develops severe hypertension (220/120 mmHg) with headache and visual changes. What is the initial blood pressure target?

A) Reduce to normal (<120/80) immediately
B) Reduce by 50% in the first hour
C) Reduce by 10-20% in the first hour
D) No reduction needed if asymptomatic
E) Reduce to 140/90 over 24 hours

Correct Answer: C) Reduce by 10-20% in the first hour

Explanation: In hypertensive emergency, blood pressure should be reduced gradually (10-20% in first hour) to avoid precipitating cerebral, cardiac, or renal ischemia from too rapid reduction.

Question 6

Which condition is most likely to present with nephritic syndrome and normal complement levels?

A) Post-infectious glomerulonephritis
B) Lupus nephritis
C) IgA nephropathy
D) Membranoproliferative glomerulonephritis
E) Acute post-streptococcal glomerulonephritis

Correct Answer: C) IgA nephropathy

Explanation: IgA nephropathy typically presents with normal complement levels, while post-infectious GN, lupus nephritis, and MPGN are associated with low complement levels.

Question 7

What is the typical latent period between streptococcal throat infection and onset of post-infectious glomerulonephritis?

A) 1-3 days
B) 1-3 weeks
C) 1-3 months
D) 3-6 months
E) 6-12 months

Correct Answer: B) 1-3 weeks

Explanation: Post-streptococcal glomerulonephritis typically occurs 1-3 weeks after throat infection (or 3-6 weeks after skin infection), reflecting the time needed for immune complex formation.

Question 8

A 25-year-old woman with lupus presents with nephritic syndrome. Which laboratory finding would be most concerning for severe lupus nephritis?

A) Positive ANA
B) Low C3 and C4
C) Elevated anti-dsDNA
D) Rapidly rising creatinine
E) Proteinuria >1 g/day

Correct Answer: D) Rapidly rising creatinine

Explanation: While all findings are concerning, rapidly rising creatinine suggests rapidly progressive lupus nephritis requiring immediate aggressive immunosuppressive therapy.

Question 9

Which medication should be avoided in patients with acute glomerulonephritis and oliguria?

A) ACE inhibitors
B) Loop diuretics
C) NSAIDs
D) Calcium channel blockers
E) Beta-blockers

Correct Answer: C) NSAIDs

Explanation: NSAIDs should be avoided in acute glomerulonephritis as they can worsen renal function by reducing glomerular filtration rate and may exacerbate acute kidney injury.

Question 10

What is the most important prognostic factor in rapidly progressive glomerulonephritis?

A) Age of the patient
B) Degree of proteinuria
C) Time to initiation of treatment
D) Presence of crescents on biopsy
E) Initial blood pressure

Correct Answer: C) Time to initiation of treatment

Explanation: In RPGN, time to treatment initiation is the most critical prognostic factor. Delays in treatment are associated with irreversible renal damage and poor outcomes.

Visual Learning Workflow